1. Medtech Insight

AHA 2019: French Registry Data Favor Edwards’ Sapien TAVR Over Medtronic’s CoreValve

The study’s authors say head-to-head randomized trials of the latest transcatheter aortic valves are urgently needed

 
• By Reed Miller

Registry data from France shows transcatheter aortic valve replacement patients have better outcomes with Edwards’ Sapien balloon-expandable valves than with Medtronic’s CoreValve self-expanding valves.

MT1911_Doctor-heart_1547988785_1200.jpg
• Source: shutterstock.com

Two analyses of French registry data showed the urgent need for a head-to-head randomized trial of the newest transcatheter aortic valve replacement (TAVR) systems, according to the studies’ authors.

A matched-propensity analysis of 12,141 patients in the FRANCE TAVI nationwide registry, treated from 2013 through 2015, showed patients with aortic stenosis treated with Medtronic’s CoreValve or CoreValve Evolut...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Clinical Trials

More from R&D